Clinical trial
Phase IIa Study of Triflusal in the Attenuation of Insulin Resistance in Men and Woman With Obesity
NCT00162799 is registered in ClinicalTrials.gov with J. Uriach and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IIa Study of Triflusal in the Attenuation of Insulin Resistance in Men and Woman With Obesity
- Lead sponsor
- J. Uriach and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- December 31, 2004
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.